The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Neonatal Diabetes Mellitus

Monogenic Diabetes Diagnosed Under 6 Months

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Neonatal Diabetes Mellitus?

Rare form of diabetes diagnosed before 6 months of age (incidence 1 in 90,000-260,000 live births).

Two main types: transient (TNDM, resolves by 18 months but may relapse) and permanent (PNDM, lifelong).

Genetic causes: KCNJ11 (Kir6.2) and ABCC8 (SUR1) mutations affecting beta-cell KATP channels (PNDM, sulfonylurea-responsive).

6q24 imprinting abnormalities (paternal duplication, ZFP57 mutation) cause most TNDM cases.

Other causes: INS, GCK, EIF2AK3 (Wolcott-Rallison), FOXP3 (IPEX), GATA6 (pancreatic agenesis), and chromosomal abnormalities.

Always consider monogenic etiology and obtain genetic testing in any infant with diabetes under 6 months.

Symptoms

Hyperglycemia (often over 250 mg/dL) detected on routine glucose check or workup for symptoms.
Failure to thrive, poor feeding, and dehydration in early life.
Polyuria, polydipsia, and weight loss in older infants.
Diabetic ketoacidosis (DKA) at presentation in some cases (more common with INS mutations).
Intrauterine growth restriction (IUGR) is common (low birth weight for gestational age).
Developmental delay, epilepsy, and motor weakness in DEND syndrome (severe KCNJ11).
Diarrhea, dermatitis, and immune dysregulation in IPEX (FOXP3).
Pancreatic agenesis: exocrine insufficiency + diabetes (GATA6, PDX1).

Risk Factors

Family history of monogenic diabetes (autosomal dominant or recessive depending on cause).
Consanguinity (recessive forms: EIF2AK3, GLIS3, PTF1A, IER3IP1).
Intrauterine growth restriction.
Multiple congenital anomalies (suggests syndromic forms).
Sibling with neonatal diabetes.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Any infant with hyperglycemia under 6 months of age.
  • Persistent hyperglycemia requiring insulin in newborn period.
  • Failure to thrive with elevated glucose values.
  • Family history of neonatal diabetes or monogenic syndromes.
  • Diabetic ketoacidosis in early infancy.
  • Genetic testing referral for any case of diabetes diagnosed under 6 months.

Treatment Methods

01
Initial management with intravenous insulin infusion to control hyperglycemia and DKA.
02
Urgent genetic testing (KCNJ11, ABCC8, INS, 6q24, GCK, etc.) to guide therapy.
03
Sulfonylurea trial (glibenclamide 0.4-1 mg/kg/day) for KCNJ11 and ABCC8 mutations; success rate over 90%.
04
Subcutaneous insulin pump or multiple daily injections for non-sulfonylurea-responsive cases.
05
Continuous glucose monitoring to optimize control and detect hypoglycemia.
06
Pancreatic enzyme replacement for GATA6/PDX1 cases with exocrine insufficiency.
07
Hematopoietic stem cell transplantation for IPEX (FOXP3).
08
Multidisciplinary follow-up: pediatric endocrinology, genetics, neurology (DEND), nutrition.
09
Long-term complications screening: developmental, neurological, cardiovascular, and metabolic monitoring.

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.